BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8690792)

  • 1. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
    Klezovitch O; Edelstein C; Scanu AM
    J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
    Klezovitch O; Scanu AM
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):392-8. PubMed ID: 8630665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10.
    Rahman MN; Becker L; Petrounevitch V; Hill BC; Jia Z; Koschinsky ML
    Biochemistry; 2002 Jan; 41(4):1149-55. PubMed ID: 11802713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
    Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
    J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
    Hermann A; Laws WR; Harpel PC
    Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
    Scanu AM; Pfaffinger D; Lee JC; Hinman J
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):41-5. PubMed ID: 7918682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.
    Hughes SD; Lou XJ; Ighani S; Verstuyft J; Grainger DJ; Lawn RM; Rubin EM
    J Clin Invest; 1997 Sep; 100(6):1493-500. PubMed ID: 9294116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
    Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
    Xue S; Madison EL; Miles LA
    Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
    Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
    J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).
    Scanu AM; Miles LA; Fless GM; Pfaffinger D; Eisenbart J; Jackson E; Hoover-Plow JL; Brunck T; Plow EF
    J Clin Invest; 1993 Jan; 91(1):283-91. PubMed ID: 8423225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
    Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.